Alteogen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alteogen Inc (196170)
Alteogen Inc stock price live, this page displays KQ 196170 stock exchange data. View the 196170 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alteogen Inc real time stock price chart below.
What Is the Alteogen Inc Stock Price Today?
The Alteogen Inc stock price today is 528,000.
What Is the Stock Symbol for Alteogen Inc?
The stock symbol for Alteogen Inc is ""196170.""
What Stock Exchange Does Alteogen Inc Trade On?
Alteogen Inc is listed and trades on the KOSDAQ stock exchange.
Is Alteogen Inc a Good Stock to Buy?
Determining whether Alteogen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 196170 quote. (ISIN: KR7196170005)
What Is the Alteogen Inc Stock Price Today?
The Alteogen Inc stock price today is 528,000.
What Is the Stock Symbol for Alteogen Inc?
The stock symbol for Alteogen Inc is ""196170.""
What Stock Exchange Does Alteogen Inc Trade On?
Alteogen Inc is listed and trades on the KOSDAQ stock exchange.
Is Alteogen Inc a Good Stock to Buy?
Determining whether Alteogen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 196170 quote. (ISIN: KR7196170005)
KOSDAQ
Currency in KRW
528,000
+10,000(+1.93%)
Delayed Data·
Fair Value
An estimate of a Alteogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
516,000
535,000
52 wk Range
274,000
569,000
196170 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Alteogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
516,000535,000
52 wk Range
274,000569,000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
196170 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Alteogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
522,000
Downside
-1.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Alteogen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alteogen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Alteogen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alteogen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alteogen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alteogen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Alteogen Inc Company Profile
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; and Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Compare 196170 to Peers and Sector
Metrics to compare | 196170 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship196170PeersSector | |
|---|---|---|---|---|
P/E Ratio | 220.0x | −5.7x | −0.6x | |
PEG Ratio | 0.05 | −0.83 | 0.00 | |
Price/Book | 74.1x | 2.5x | 2.6x | |
Price / LTM Sales | 137.0x | 10.5x | 3.3x | |
Upside (Analyst Target) | 13.9% | 11.6% | 40.3% | |
Fair Value Upside | Unlock | 3.4% | 3.9% | Unlock |
Analyst Ratings
4 Buy
0 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 522,000
(-1.14% Downside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
379.35 / 379.35
Revenue / Forecast
49.00B / 59.19B
People Also Watch
FAQ
What Stock Exchange Does Alteogen Trade On?
Alteogen is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Alteogen?
The stock symbol for Alteogen is "196170."
What Is the Alteogen Market Cap?
As of today, Alteogen market cap is 27.70T.
What Is Alteogen's Earnings Per Share (TTM)?
The Alteogen EPS (TTM) is 2,232.03.
When Is the Next Alteogen Earnings Date?
Alteogen will release its next earnings report on 22 Mar 2026.
From a Technical Analysis Perspective, Is 196170 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Alteogen Stock Split?
Alteogen has split 4 times.
How Many Employees Does Alteogen Have?
Alteogen has 155 employees.
What is the current trading status of Alteogen (196170)?
As of 27 Nov 2025, Alteogen (196170) is trading at a price of 528,000, with a previous close of 518,000. The stock has fluctuated within a day range of 516,000 to 535,000, while its 52-week range spans from 274,000 to 569,000.
What Is Alteogen (196170) Price Target According to Analysts?
The average 12-month price target for Alteogen is KRW522000, with a high estimate of KRW730000 and a low estimate of KRW270000. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -1.14% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.